|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,183.40 INR | -0.58% |
|
-4.76% | -6.90% |
| Jan. 13 | Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading | MT |
| Jan. 13 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.28 | 8.04 | 10.86 | 11.51 | 10.37 | |||||
Return on Total Capital | 10.83 | 10.5 | 14.24 | 14.98 | 13.34 | |||||
Return On Equity % | 10.51 | 12.96 | 21.38 | 21.77 | 18.53 | |||||
Return on Common Equity | 10.51 | 12.96 | 21.38 | 21.77 | 18.42 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 54.33 | 53.1 | 56.67 | 58.61 | 58.5 | |||||
SG&A Margin | 28.77 | 28.96 | 27.67 | 27.65 | 28.52 | |||||
EBITDA Margin % | 23.68 | 21.87 | 26.51 | 28.3 | 27.29 | |||||
EBITA Margin % | 19.63 | 18.47 | 23.36 | 25.28 | 24.45 | |||||
EBIT Margin % | 17.38 | 16.75 | 21.72 | 23.39 | 22.43 | |||||
Income From Continuing Operations Margin % | 9.09 | 10.99 | 18.33 | 19.95 | 17.58 | |||||
Net Income Margin % | 9.09 | 10.99 | 18.33 | 19.95 | 17.37 | |||||
Net Avail. For Common Margin % | 9.09 | 10.99 | 18.33 | 19.95 | 17.37 | |||||
Normalized Net Income Margin | 11.38 | 11.21 | 14.17 | 14.85 | 14.75 | |||||
Levered Free Cash Flow Margin | 10.17 | 0.48 | 10.98 | 4.38 | 3.66 | |||||
Unlevered Free Cash Flow Margin | 10.49 | 0.76 | 11.34 | 4.76 | 4.2 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.76 | 0.77 | 0.8 | 0.79 | 0.74 | |||||
Fixed Assets Turnover | 3.47 | 3.59 | 3.82 | 3.89 | 3.73 | |||||
Receivables Turnover (Average Receivables) | 3.8 | 3.68 | 3.53 | 3.65 | 3.81 | |||||
Inventory Turnover (Average Inventory) | 2.15 | 2.09 | 2.14 | 2.06 | 2.01 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.78 | 1.93 | 2.41 | 2.58 | 1.92 | |||||
Quick Ratio | 1.07 | 1.24 | 1.6 | 1.71 | 1.16 | |||||
Operating Cash Flow to Current Liabilities | 0.43 | 0.3 | 0.69 | 0.47 | 0.36 | |||||
Days Sales Outstanding (Average Receivables) | 96.12 | 99.09 | 103.36 | 100.15 | 95.71 | |||||
Days Outstanding Inventory (Average Inventory) | 169.51 | 174.78 | 170.54 | 177.72 | 181.86 | |||||
Average Days Payable Outstanding | 44.11 | 49.35 | 59.18 | 55.28 | 53.22 | |||||
Cash Conversion Cycle (Average Days) | 221.52 | 224.52 | 214.72 | 222.59 | 224.35 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 17.51 | 17.76 | 5.83 | 7.14 | 13.87 | |||||
Total Debt / Total Capital | 14.9 | 15.08 | 5.51 | 6.66 | 12.18 | |||||
LT Debt/Equity | 3.64 | 3.02 | 0.55 | 2.14 | 2.33 | |||||
Long-Term Debt / Total Capital | 3.1 | 2.56 | 0.52 | 1.99 | 2.05 | |||||
Total Liabilities / Total Assets | 34.81 | 34.94 | 28.23 | 27.6 | 31.61 | |||||
EBIT / Interest Expense | 33.99 | 37.49 | 37.41 | 38.17 | 25.82 | |||||
EBITDA / Interest Expense | 47.18 | 49.84 | 46.25 | 46.84 | 31.84 | |||||
(EBITDA - Capex) / Interest Expense | 37.14 | 34.53 | 38.33 | 37.26 | 22.12 | |||||
Total Debt / EBITDA | 0.66 | 0.71 | 0.2 | 0.25 | 0.52 | |||||
Net Debt / EBITDA | -0.09 | -0.22 | -0.73 | -0.77 | -0.12 | |||||
Total Debt / (EBITDA - Capex) | 0.84 | 1.02 | 0.25 | 0.31 | 0.75 | |||||
Net Debt / (EBITDA - Capex) | -0.12 | -0.32 | -0.88 | -0.96 | -0.18 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.66 | 13 | 14.69 | 13.54 | 16.61 | |||||
Gross Profit, 1 Yr. Growth % | 9.65 | 10.44 | 22.4 | 17.41 | 16.39 | |||||
EBITDA, 1 Yr. Growth % | 8.82 | 4.34 | 39.01 | 21.22 | 12.05 | |||||
EBITA, 1 Yr. Growth % | 12.35 | 6.32 | 45.08 | 22.87 | 12.32 | |||||
EBIT, 1 Yr. Growth % | 12.48 | 8.94 | 48.71 | 22.26 | 11.35 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -11.59 | 36.72 | 91.22 | 23.56 | 2.8 | |||||
Net Income, 1 Yr. Growth % | -11.59 | 36.72 | 91.22 | 23.56 | 1.54 | |||||
Normalized Net Income, 1 Yr. Growth % | 13.55 | 11.34 | 44.97 | 19.3 | 10.21 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -11.71 | 36.7 | 91.16 | 23.32 | 1.47 | |||||
Accounts Receivable, 1 Yr. Growth % | -1.27 | 34.49 | 8.57 | 10.78 | 12.61 | |||||
Inventory, 1 Yr. Growth % | 29.5 | 12.05 | -4.35 | 30.58 | 11.85 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 9.13 | 8.86 | 6.91 | 15.68 | 27.15 | |||||
Total Assets, 1 Yr. Growth % | 14.32 | 10.3 | 9.91 | 20.4 | 27.22 | |||||
Tangible Book Value, 1 Yr. Growth % | 7.71 | 19.58 | 23.31 | 22.18 | -6.09 | |||||
Common Equity, 1 Yr. Growth % | 11.66 | 10.09 | 21.24 | 21.45 | 18.83 | |||||
Cash From Operations, 1 Yr. Growth % | 19.64 | -21.27 | 109.46 | -22.83 | 2.19 | |||||
Capital Expenditures, 1 Yr. Growth % | 101.01 | 50.5 | -22.76 | 44.86 | 67.68 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 2.92 | -94.66 | 2.52K | -58.79 | -3.92 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 2.79 | -91.81 | 1.61K | -56.49 | 1.58 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 20 | 33.33 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.05 | 10.81 | 13.84 | 14.11 | 15.06 | |||||
Gross Profit, 2 Yr. CAGR % | 11.15 | 10.04 | 16.27 | 19.88 | 16.9 | |||||
EBITDA, 2 Yr. CAGR % | 18.75 | 5.93 | 19.41 | 28.64 | 15.97 | |||||
EBITA, 2 Yr. CAGR % | 25.87 | 9.29 | 24.29 | 33.51 | 17.71 | |||||
EBIT, 2 Yr. CAGR % | 29.45 | 10.7 | 27.4 | 34.84 | 16.93 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -4.23 | 9.94 | 61.69 | 53.71 | 12.7 | |||||
Net Income, 2 Yr. CAGR % | -4.23 | 9.94 | 61.69 | 53.71 | 12.01 | |||||
Normalized Net Income, 2 Yr. CAGR % | 29.95 | 12.44 | 26.15 | 30.86 | 16.48 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -4.26 | 9.86 | 61.65 | 53.54 | 11.86 | |||||
Accounts Receivable, 2 Yr. CAGR % | 11.58 | 15.23 | 20.84 | 9.67 | 11.69 | |||||
Inventory, 2 Yr. CAGR % | 16.29 | 20.46 | 3.52 | 11.76 | 20.85 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.76 | 8.99 | 7.88 | 11.21 | 21.28 | |||||
Total Assets, 2 Yr. CAGR % | 8.52 | 12.29 | 10.1 | 15.04 | 23.76 | |||||
Tangible Book Value, 2 Yr. CAGR % | 20.21 | 13.49 | 21.43 | 22.74 | 7.12 | |||||
Common Equity, 2 Yr. CAGR % | 11.1 | 10.87 | 15.53 | 21.35 | 20.14 | |||||
Cash From Operations, 2 Yr. CAGR % | 11.53 | -2.95 | 28.41 | 27.14 | -11.2 | |||||
Capital Expenditures, 2 Yr. CAGR % | 18.35 | 73.93 | 7.81 | 5.78 | 55.85 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 13.05 | -76.55 | 18.38 | 244.49 | -36.62 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 12.75 | -70.99 | 18.47 | 185.71 | -33.08 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.8 | 9.54 | 26.49 | 15.47 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 10.18 | 11.7 | 12.09 | 13.74 | 14.94 | |||||
Gross Profit, 3 Yr. CAGR % | 10.54 | 10.92 | 14.02 | 16.65 | 18.71 | |||||
EBITDA, 3 Yr. CAGR % | 23.71 | 13.74 | 15.97 | 20.01 | 23 | |||||
EBITA, 3 Yr. CAGR % | 34.08 | 18.98 | 20.11 | 23.82 | 26.2 | |||||
EBIT, 3 Yr. CAGR % | 39.96 | 22.22 | 22.14 | 25.66 | 26.69 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 20.69 | 7.84 | 32.22 | 47.82 | 34.42 | |||||
Net Income, 3 Yr. CAGR % | 20.69 | 7.84 | 32.22 | 47.82 | 33.87 | |||||
Normalized Net Income, 3 Yr. CAGR % | 41.56 | 23.43 | 22.38 | 23.71 | 25.65 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 20.66 | 7.8 | 32.14 | 47.71 | 33.73 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.92 | 18.75 | 12.97 | 17.39 | 10.64 | |||||
Inventory, 3 Yr. CAGR % | 16.01 | 14.86 | 11.55 | 11.85 | 11.79 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -0.44 | 4.75 | 8.29 | 10.42 | 16.29 | |||||
Total Assets, 3 Yr. CAGR % | 5.58 | 9.11 | 11.49 | 13.44 | 18.96 | |||||
Tangible Book Value, 3 Yr. CAGR % | 19.5 | 20 | 16.68 | 21.68 | 12.26 | |||||
Common Equity, 3 Yr. CAGR % | 11.02 | 10.77 | 14.23 | 17.47 | 20.5 | |||||
Cash From Operations, 3 Yr. CAGR % | 25.58 | -0.7 | 25.42 | 8.36 | 18.21 | |||||
Capital Expenditures, 3 Yr. CAGR % | 1.59 | 28.22 | 32.7 | 18.97 | 23.34 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 62.02 | -59.13 | 12.91 | -14.04 | 126.15 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 58.17 | -52.96 | 12.92 | -12.52 | 103.29 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.72 | 14.47 | 16.96 | 16.96 | 10.06 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.28 | 8.92 | 11.63 | 12.66 | 13.27 | |||||
Gross Profit, 5 Yr. CAGR % | 2.24 | 7.76 | 12.8 | 14.42 | 15.16 | |||||
EBITDA, 5 Yr. CAGR % | 2.26 | 13.82 | 22.39 | 19.91 | 16.28 | |||||
EBITA, 5 Yr. CAGR % | 2.2 | 18.49 | 30.03 | 24.6 | 19.15 | |||||
EBIT, 5 Yr. CAGR % | 1.96 | 22.03 | 34.75 | 27.12 | 20.03 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -2.94 | 14.38 | 35.67 | 24.26 | 24.04 | |||||
Net Income, 5 Yr. CAGR % | -2.94 | 14.38 | 35.67 | 24.26 | 23.73 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.05 | 23.35 | 35.56 | 26.53 | 20.36 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -2.39 | 14.47 | 35.64 | 24.19 | 23.62 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.74 | 11.89 | 12.28 | 15.03 | 12.45 | |||||
Inventory, 5 Yr. CAGR % | 12.17 | 12.27 | 10.84 | 13.61 | 15.18 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.14 | 1.69 | 2.81 | 7.29 | 13.31 | |||||
Total Assets, 5 Yr. CAGR % | 5.04 | 5.9 | 7.36 | 11.44 | 16.25 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.08 | 16.08 | 20.27 | 21.09 | 12.75 | |||||
Common Equity, 5 Yr. CAGR % | 6.16 | 8.96 | 12.8 | 14.88 | 16.55 | |||||
Cash From Operations, 5 Yr. CAGR % | -2.85 | 5.49 | 26.7 | 9.62 | 9.24 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.11 | 3.61 | 4.04 | 18.72 | 41.52 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -1.8 | -46.93 | 42.85 | -4.13 | -8.66 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -1.66 | -41.64 | 40.85 | -3.21 | -6.7 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.56 | 8.45 | 14.87 | 14.87 | 9.86 |
Select your edition
All financial news and data tailored to specific country editions
















